Detalles de la búsqueda
1.
Tenofovir-Diphosphate and Emtricitabine-Triphosphate Adherence Benchmarks in Dried Blood Spots for Persons with HIV Receiving Tenofovir Alafenamide and Emtricitabine-based Antiretroviral Therapy (QUANTI-TAF).
Clin Infect Dis
; 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38636950
2.
Acceptability and Feasibility of Providing Adherence Feedback Based on Tenofovir Diphosphate in Dried Blood Spots: Results from a Pilot Study Among Patients and Providers in Cape Town, South Africa.
AIDS Behav
; 27(10): 3478-3486, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37043053
3.
Predictors of 007 triphosphate concentrations in dried blood spots in persons with hepatitis C and active drug or alcohol use.
J Antimicrob Chemother
; 77(5): 1396-1403, 2022 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35194648
4.
High residual inflammation despite HIV viral suppression: Lessons learned from real-time adherence monitoring among people with HIV in Africa.
HIV Med
; 23(5): 465-473, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34704355
5.
Factors associated with tenofovir diphosphate concentrations in dried blood spots in persons living with HIV.
J Antimicrob Chemother
; 75(6): 1591-1598, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32211787
6.
Pharmacokinetics and renal safety of tenofovir alafenamide with boosted protease inhibitors and ledipasvir/sofosbuvir.
J Antimicrob Chemother
; 75(11): 3303-3310, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32766700
7.
Predictive Value of Tenofovir Diphosphate in Dried Blood Spots for Future Viremia in Persons Living With HIV.
J Infect Dis
; 220(4): 635-642, 2019 07 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30942881
8.
Tenofovir Diphosphate in Dried Blood Spots Is Strongly Associated With Viral Suppression in Individuals With Human Immunodeficiency Virus Infections.
Clin Infect Dis
; 68(8): 1335-1342, 2019 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30137238
9.
Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarate.
J Antimicrob Chemother
; 74(8): 2352-2359, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31093649
10.
Increased tenofovir monoester concentrations in patients receiving tenofovir disoproxil fumarate with ledipasvir/sofosbuvir.
J Antimicrob Chemother
; 74(8): 2360-2364, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31081036
11.
Engagement in Mental Health Care is Associated with Higher Cumulative Drug Exposure and Adherence to Antiretroviral Therapy.
AIDS Behav
; 23(12): 3493-3502, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30798457
12.
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy.
Antimicrob Agents Chemother
; 62(1)2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29038282
13.
Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate.
J Antimicrob Chemother
; 73(8): 2112-2119, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29746648
14.
Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring.
Curr HIV/AIDS Rep
; 15(1): 49-59, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29380227
15.
Long-acting injectable Cabotegravir: How drug concentrations could help guide patient management.
Br J Clin Pharmacol
; 88(10): 4384-4386, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35971819
16.
Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression.
Clin Infect Dis
; 63(12): 1661-1667, 2016 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27660234
17.
Analysis of the Endogenous Deoxynucleoside Triphosphate Pool in HIV-Positive and -Negative Individuals Receiving Tenofovir-Emtricitabine.
Antimicrob Agents Chemother
; 60(9): 5387-92, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27353267
18.
Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).
J Antimicrob Chemother
; 71(6): 1609-18, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26892777
19.
Adherence to Antiretroviral Therapy and Pre-exposure Prophylaxis: TARGETing the Ideal Measure.
Clin Infect Dis
; 70(10): 2152-2154, 2020 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31314075
20.
Dose response for starting and stopping HIV preexposure prophylaxis for men who have sex with men.
Clin Infect Dis
; 60(5): 804-10, 2015 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25409469